Testing a new medication to help manage sickle cell disease symptoms

This is an early-stage study testing a new medication called fostamatinib in people with sickle cell disease. The main goal is to understand if the medication is safe and how well it works when taken by mouth. Researchers also want to see if fostamatinib might help reduce inflammation and improve how red blood cells function in people with this condition.

Sickle cell disease causes pain, organ damage, and other serious complications. This medication works differently than current treatments by targeting inflammation and potentially helping red blood cells stay healthier, which could offer a new way to help people manage their disease.